Abstract
Objective
Angiotensin(1–7) is an active component of the renin–angiotensin–aldosterone system. Its exact role in renal vascular function is unclear. We therefore studied the effects of angiotensin(1–7) on the renal vasculature in vitro and in vivo.
Methods
Isolated small renal arteries were studied in an arteriograph system by constructing concentration–response curves to angiotensin II, without and with angiotensin(1–7). In isolated perfused kidneys, the response of angiotensin II on renal vascular resistance was measured without and with angiotensin(1–7). The influence of angiotensin(1–7) on angiotensin II-induced glomerular afferent and efferent constriction was assessed with intravital microscopy in vivo under anaesthesia. In freely moving rats, we studied the effect of angiotensin(1–7) on angiotensin II-induced reduction of renal blood flow with an electromagnetic flow probe.
Results
Angiotensin(1–7) alone had no effect on the renal vasculature in any of the experiments. In vitro, angiotensin(1–7) antagonized angiotensin-II-induced constriction of isolated renal arteries (9.71 ± 1.21 and 3.20 ± 0.57%, for control and angiotensin(1–7) pre-treated arteries, respectively; P < 0.0005). In isolated perfused kidneys, angiotensin(1–7) reduced the angiotensin II response (100 ± 16.6 versus 72.6 ± 15.6%, P < 0.05) and shifted the angiotensin II dose–response curve rightward (pEC50, 6.69 ± 0.19 and 6.26 ± 0.12 for control and angiotensin(1–7) pre-treated kidneys, respectively; P < 0.05). Angiotensin(1–7), however, was devoid of effects on angiotensin-II-induced constriction of glomerular afferent and efferent arterioles and on angiotensin-II-induced renal blood flow reduction in freely moving rats in vivo.
Conclusion
Angiotensin(1–7) antagonizes angiotensin II in renal vessels in vitro, but does not appear to have a major function in normal physiological regulation of renal vascular function in vivo.
Angiotensin(1–7) is an active component of the renin–angiotensin–aldosterone system. Its exact role in renal vascular function is unclear. We therefore studied the effects of angiotensin(1–7) on the renal vasculature in vitro and in vivo.
Methods
Isolated small renal arteries were studied in an arteriograph system by constructing concentration–response curves to angiotensin II, without and with angiotensin(1–7). In isolated perfused kidneys, the response of angiotensin II on renal vascular resistance was measured without and with angiotensin(1–7). The influence of angiotensin(1–7) on angiotensin II-induced glomerular afferent and efferent constriction was assessed with intravital microscopy in vivo under anaesthesia. In freely moving rats, we studied the effect of angiotensin(1–7) on angiotensin II-induced reduction of renal blood flow with an electromagnetic flow probe.
Results
Angiotensin(1–7) alone had no effect on the renal vasculature in any of the experiments. In vitro, angiotensin(1–7) antagonized angiotensin-II-induced constriction of isolated renal arteries (9.71 ± 1.21 and 3.20 ± 0.57%, for control and angiotensin(1–7) pre-treated arteries, respectively; P < 0.0005). In isolated perfused kidneys, angiotensin(1–7) reduced the angiotensin II response (100 ± 16.6 versus 72.6 ± 15.6%, P < 0.05) and shifted the angiotensin II dose–response curve rightward (pEC50, 6.69 ± 0.19 and 6.26 ± 0.12 for control and angiotensin(1–7) pre-treated kidneys, respectively; P < 0.05). Angiotensin(1–7), however, was devoid of effects on angiotensin-II-induced constriction of glomerular afferent and efferent arterioles and on angiotensin-II-induced renal blood flow reduction in freely moving rats in vivo.
Conclusion
Angiotensin(1–7) antagonizes angiotensin II in renal vessels in vitro, but does not appear to have a major function in normal physiological regulation of renal vascular function in vivo.
| Original language | English |
|---|---|
| Journal | Journal of Hypertension |
| Volume | 24 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Oct 2006 |